AIAI Holdings Corporation (AIAI)

NetraMark Founder Dr. Joseph Geraci to Participate in H.C. Wainwright's AI-Based Drug Discovery and Development Conference

AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement

AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare

AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value

AIAI Holdings Announces Letter of Intent with Messier 42 LLC to Acquire Controlling Interest in Defense & National Security Company

NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier

AIAI Holdings Commences Discussions with Messier 42 LLC Regarding Acquisition Opportunities

NetraMark Corporate Update Highlights Record C$3.4 Million in Fiscal 2026 Contract Bookings, Up 645% from Previous Annual High

AIAI Holdings' CEO Todd Furniss Issues Shareholder Letter

AIAI Holdings' Constellation Network Launches Dôr Retail Intelligence: Transformational AI-Powered Retail Intelligence

AIAI Holdings' MediGuide Launches Longevity Intelligence, Redefining Personalized Preventive Healthcare

AIAI Deploys Bid Accelerator, Showcasing Its Transformational AI Integration Strategy

AIAI Holdings' MediGuide Enters the State-of-the-Art Medicine Market With AI-Driven Innovation

NetraMark Signs New Contract To Analyze Phase 2 Neurodegeneration Trial Data With Contract Research Organization Partner

AIAI Holdings' Constellation Network Launches Gate AI: Real-Time Security for AI Applications